Contribution of transmembrane tumor necrosis factor to host defense against Mycobacterium bovis bacillus Calmette-guerin and Mycobacterium tuberculosis infections.
about
Tumour necrosis factor-mediated macrophage activation in the target organ is critical for clinical manifestation of uveitisMembrane TNF confers protection to acute mycobacterial infection.Differences in reactivation of tuberculosis induced from anti-TNF treatments are based on bioavailability in granulomatous tissueIdentification of key processes that control tumor necrosis factor availability in a tuberculosis granulomaMultiscale computational modeling reveals a critical role for TNF-α receptor 1 dynamics in tuberculosis granuloma formation.Immune subversion by Mycobacterium tuberculosis through CCR5 mediated signaling: involvement of IL-10Discriminators of mouse bladder response to intravesical Bacillus Calmette-Guerin (BCG).Transmembrane TNF-alpha: structure, function and interaction with anti-TNF agents.Reactivation of M. tuberculosis infection in trans-membrane tumour necrosis factor mice.Bacillus calmette-guerin infection in NADPH oxidase deficiency: defective mycobacterial sequestration and granuloma formation.Delayed dominant-negative TNF gene therapy halts progressive loss of nigral dopaminergic neurons in a rat model of Parkinson's diseaseHow tumour necrosis factor blockers interfere with tuberculosis immunity.Differential requirements for soluble and transmembrane tumor necrosis factor in the immunological control of primary and secondary Listeria monocytogenes infectionMembrane tumor necrosis factor confers partial protection to Listeria infection.Inhibition of soluble tumour necrosis factor is therapeutic in experimental autoimmune encephalomyelitis and promotes axon preservation and remyelinationDifferential risk of tuberculosis reactivation among anti-TNF therapies is due to drug binding kinetics and permeability.The safety of etanercept for the treatment of plaque psoriasis.Hypercapnia: a nonpermissive environment for the lung.Biologic therapies in rheumatology: lessons learned, future directions.Phthiocerol dimycocerosate transport is required for resisting interferon-gamma-independent immunity.Blocking soluble tumor necrosis factor signaling with dominant-negative tumor necrosis factor inhibitor attenuates loss of dopaminergic neurons in models of Parkinson's diseaseTumor necrosis factor neutralization combined with chemotherapy enhances Mycobacterium tuberculosis clearance and reduces lung pathology.Protective role of membrane tumour necrosis factor in the host's resistance to mycobacterial infection.Mycobacterium marinum: a potential immunotherapy for Mycobacterium tuberculosis infection.Soluble TNFRp75 regulates host protective immunity against Mycobacterium tuberculosis.Do RANKL inhibitors (denosumab) affect inflammation and immunity?Kinoids: a family of immunogens for active anticytokine immunotherapy applied to autoimmune diseases and cancer.Role of innate cytokines in mycobacterial infection.New insights into gastrointestinal and hepatic granulomatous disorders.Inflammatory Cytokines Are Involved in Focal Demyelination in Leprosy Neuritis.Transmembrane Tumor Necrosis Factor Controls Myeloid-Derived Suppressor Cell Activity via TNF Receptor 2 and Protects from Excessive Inflammation during BCG-Induced Pleurisy.Targeting ADAM17 in leukocytes increases neutrophil recruitment and reduces bacterial spread during polymicrobial sepsis.Involvement of caspase-9 in the inhibition of necrosis of RAW 264 cells infected with Mycobacterium tuberculosis.Neutralization of membrane TNF, but not soluble TNF, is crucial for the treatment of experimental colitis.WC1(+) gammadelta T cells indirectly regulate chemokine production during mycobacterium bovis infection in SCID-bo mice.
P2860
Q24633598-48006B80-23E6-4056-B54D-D77A66732707Q25257300-5D786235-CFAB-4B50-AED4-CB43D9C83537Q28469340-EEC5F5B2-55EA-43E4-B156-49F624BBBC46Q28473855-E72785E4-2E17-46DC-8DF7-7F01A248DAB1Q30501800-2B490EE7-DBC8-47B0-8C47-89A2C4B56250Q31155201-33BF56B3-B7D0-45F0-8D71-8E4AC91ACEA9Q33284823-952A4298-57C4-44F8-840D-67EFF6CAE78FQ33915940-449B2133-6CBA-44A4-9660-CE305F3170F7Q34087566-9F4D753E-4726-4F55-A076-13EC0594218FQ34134720-758CA0A3-F87A-4AC2-8785-A81DCA3CEF26Q34473323-D3BCA24E-A18A-4274-893C-6439F92AECB7Q34660051-E642B016-5D96-4CB6-8576-A49D7CA354CAQ34681089-AC144FD3-14DB-4990-97F2-15E542465B8DQ35094506-AC38B10E-042E-455C-B725-3CD4ECDC6D29Q35206971-A9B90A68-F6D9-4056-9AE9-B26208D844B9Q35851073-EF094BC5-24FB-4478-B53D-211667919D17Q35919214-E3C615C5-CB43-438C-B2E5-0478CCB76353Q35987294-C410E5D7-FA1F-471E-9DFB-34D69B983DFCQ36694805-2AFBB0B2-CB5A-4A4C-A6AA-5F9C7336F580Q36914816-47235459-D8EA-4039-BDF2-8541EDCF76A5Q36998952-967C8A56-4381-4BF5-B32B-A77A08C23376Q37021677-CE830E14-1E51-4F32-816B-437932301C08Q37033735-C310347D-810F-43E1-B0CC-14F9CB093DEDQ37071295-5FB1D064-68C8-4B42-8516-5733FE314FFCQ37679983-17DAC66B-35EC-4BFB-8B2E-DA54B0EC226AQ37767159-BF15B597-8EAA-4140-BC00-FFD5F6D1B0A5Q37773243-E1AAF332-0256-4785-B8FB-E39AF1EF577FQ37856711-D592E7FE-E82D-4293-B485-B9985480A224Q37911957-9DF2003B-1719-4CD9-8791-0421A1579BBAQ38793309-B5B0D304-F641-4E90-A6DF-30508D65C3DDQ40054580-6382B8E4-96DC-4BDB-A3CC-8372111AD62AQ40473951-FE6C8D77-43DC-4B4F-B52B-D51DE271F688Q42432593-6F68D294-85DD-4D02-9D8E-F21176E82315Q45773011-1B938734-4C5D-44D3-8AE5-3BBE50AAA89DQ47680606-1ED3091A-320A-4F64-B531-264DFC7F999B
P2860
Contribution of transmembrane tumor necrosis factor to host defense against Mycobacterium bovis bacillus Calmette-guerin and Mycobacterium tuberculosis infections.
description
2005 nî lūn-bûn
@nan
2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Contribution of transmembrane ...... erium tuberculosis infections.
@ast
Contribution of transmembrane ...... erium tuberculosis infections.
@en
type
label
Contribution of transmembrane ...... erium tuberculosis infections.
@ast
Contribution of transmembrane ...... erium tuberculosis infections.
@en
prefLabel
Contribution of transmembrane ...... erium tuberculosis infections.
@ast
Contribution of transmembrane ...... erium tuberculosis infections.
@en
P2093
P2860
P1476
Contribution of transmembrane ...... terium tuberculosis infections
@en
P2093
Dominique Vesin
Eduardo Martinez-Soria
Gilles Marchal
Irene Garcia
Jean-Claude Pache
Maria L Olleros
Nadia Corazza
Reto Guler
Roumen Parapanov
P2860
P304
P356
10.1016/S0002-9440(10)62331-0
P407
P577
2005-04-01T00:00:00Z